Anika Therapeutics ANIK Deferred taxes
Deferred taxes at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Anika Therapeutics’s 8-K, filed July 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Anika Therapeutics's deferred taxes?
- Anika Therapeutics (ANIK) reported deferred taxes of $129K in Q2 2026.
- How has Anika Therapeutics's deferred taxes changed year-over-year?
- Anika Therapeutics's deferred taxes increased by 4400.0% year-over-year, from -$3K to $129K.
- What is the long-term trend for Anika Therapeutics's deferred taxes?
- Over 3 years (2021 to 2025), Anika Therapeutics's deferred taxes has grown at a -84.2% compound annual growth rate (CAGR), from -$1.77M to -$7K.